DEVELOPING CONCEPTIONS OF ANTIPHOSPHOLIPID SYNDROME AND THEIR MEANING FOR NEUROLOGY



Cite item

Full Text

Abstract

There were covered a short history and modern pathogenetic hypothesis of antiphospholipid syndrome - a pathological state, characterized by thrombotic complications. Role of antiphospholipid antibodies in development of non-thrombic autoimmune diseases including those, accompanied by nervous system lesions, was considered.

About the authors

Laily D Zubairova

Kazan State Medical University of the Russian health ministry

Email: zubairovalaily@gmail.com
кафедра патофизиологии; ГОУ ВПО «Казанский государственный медицинский университет Росздрава»; Kazan State Medical University of the Russian health ministry

Dilyaver M Zubairov

Kazan State Medical University of the Russian health ministry

кафедра биохимии; ГОУ ВПО «Казанский государственный медицинский университет Росздрава»; Kazan State Medical University of the Russian health ministry

References

  1. Баркаган, З.С. Принципы лабораторной диагностики антифосфолипидного синдрома / З.С. Баркаган, А.П. Момот, Л.П. Цывкина и др. // Клин. лабор. диагностика. - 2000. - №3. - С. 47-51.
  2. Джамантаева, Б.Д. Первичный антифосфолипидный синдром, имитирующий рассеянный склероз: Автореф. дисс. … канд. мед. наук. - М., 2007. - 29 с.
  3. Зубаиров, Д.М. Патофизиологическое и клинико-диагностическое значение микровезикуляции в крови / Д.М. Зубаиров, И.А. Андрушко, Л.Д. Зубаирова // Гематол. и трансфузиол. - 1999. - Т. 44, №5. - С. 24-30.
  4. Зубаиров, Д.М. Молекулярные основы свертывания крови и тромбообразования. -Казань: ФЭН, 2000. - 367 с.
  5. Зубаиров, Д.М. Пертурбация эндотелия - причина острой гиперкоагулемии / Д.М. Зубаиров, И.А. Андрушко, Л.Д. Зубаирова, Г.Ю. Свинтенок // Казанский мед. ж. - 2002. - Т.83, №5. - С. 327-333.
  6. Калашникова, Л.А. Неврология антифосфолипидного синдрома. - М: Медицина, 2003. - 256 с.
  7. Калашникова, Л.А. Неишемические неврологические проявления у больных первичным антифосфолипидным синдромом // Журн. неврол. и психиатр. им. C.C. Корсакова. - 2005. - Т. 105, №2. - С. 18-23.
  8. Киселев, С.В. Влияние волчаночноподобного анти-коагулянта на взаимодействие протромбина и тромбоцитов / С.В. Киселев, Д.М. Зубаиров, И.А. Андушко, Ю.Л. Кацадзе // Бюлл. экспер. биол. - 2004.- Т.136, №6. - С. 614-617.
  9. Arnout, J. Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease / J. Arnout, J. Vermylen // J. Thromb. Haemost. - 2003. - Vol.1, №5. - Р. 931-942.
  10. Atanassova, P.A. Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: An overview // Yonsei Med. J. - 2007. - Vol.48, №6. - Р. 901-926.
  11. Bidot, C.J. Factor VII/VIIa: A new antigen in the antiphospholipid antibody syndrome / Bidot C.J., Jy W., Horstman L.L. et al. // Br. J. Haematol. - 2003. - Vol.120, №4. - Р. 618-626.
  12. Bidot C.J. Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis / C.J. Bidot, L.L. Horstman, W. Jy et al. // BMC Neurol. - 2007. - Vol.7, №36. - Р. 36-42.
  13. Borrell, E.M. Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells / E.M. Borrell, N. Sala, C. de Castellarnau et al. // J. Thromb. Haemost. -1992. - Vol. 68, №3. - Р. 268-272.
  14. Cabiedes, J. Hidden anti-phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospho-lipase treatment / J. Cabiedes, A.R. Cabral, D. Alarcon-Segovia // Eur. J. Immunol. - 1998. - Vol. 28, №7. - Р. 2108-2114.
  15. Cabiedes, J. Characterization of anti-phosphatidylcholine polyreactive natural autoantibodies from normal human subjects / J. Cabiedes, A.R. Cabral, A.T. Lopez-Mendoza et al. // J. Autoimm. - 2002. - Vol.18, №2. - Р. 181-190.
  16. Caronti, B. Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells / B. Caronti, C. Calderaro, C. Alessandri et al. // J. Autoimmun. - 1998. - Vol.11, №5. - Р. 425-429.
  17. Chapman, J. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes / J. Chapman, M. Cohen-Armon, Y. Shoenfeld, A.D. Korczyn // Lupus. - 1999. - Vol. 8, №2. - Р. 127-133.
  18. Combes, V. In vitro generation of endothelial micro-particles and possible prothrombotic activity in patients with lupus anticoagulant / V. Combes, A.C. Simon, G.E. Grau et al. // J. Clin. Invest. - 1999. - Vol.104, №1. - Р. 93-102.
  19. Comp, P.C. Human thrombomodulin is inhibited by IgG from two patients with non-specific anticoagulants / P.C. Comp, L.E. DeBault, N.L. Esmon, C.T. Esmon // Blood. - 1983. -Vol. 62. - Р. 299-309.
  20. Conley, C.L. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus / C.L. Conley, R.C. Hartman // J. Clin. Invest. -1952. - Vol. 31. - Р. 621-622.
  21. Day, H.M. Autoantibodies to в2-glycoprotein 1 in syste-mic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other anti-phospholipid antibody tests / H.M. Day, P. Thiagarajan, C. Ahn et al. // J. Rheumatol. -1998. - Vol. 25, №4. - Р. 667-674.
  22. Dignat-George, F. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospho-lipid syndrome / F. Dignat-George, L. Camoin-Jau, F. Sabatier et al. // Thromb. Haemost. - 2004. - Vol. 91, №4. - Р. 667-673.
  23. Donohoe, S. Ontogony of в2 glycoprotein 1 and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies / S. Donohoe, J.C.P. Kingdom, I.J. Mackie et al. // J. Thromb. Haemost. - 2000. - Vol. 84, №1. - Р. 32-38.
  24. Forastiero, R.R. High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome / R.R. Forastiero, M.E. Maetinuzzo, G.J. Jr. Broze // J. Thromb. Haemost. - 2003. - Vol. 1, №4. - Р. 718-724.
  25. Galli, M. Anti-beta-2-glycoprotein 1, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome / M. Galli, D. Luciani, G. Bertolini, T. Barbui // Blood. - 2003. - Vol. 102, №8. - Р. 2717-2713.
  26. Galli, M. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome // Sem. Thromb. Hemost. - 2008. - Vol. 34, №4. - Р. 329-334.
  27. Han, M.H. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets / M.H. Han, S.U. Hwang, D.B. Roy et al. // Nature. - 2008. - Vol. 451, №7182. - Р. 1076-1080.
  28. Harris, E.N. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus / E.N. Harris, A.E. Charavi, M.L. Boey et al. // Lancet. - 1983. - Vol. 2. - Р. 1211-1214.
  29. Hughes, G.R.V. The anticardiolipin syndrome / G.R.V. Hughes, E.N. Harris, A.E. Gharavi // J. Rheumatol. - 1985. - Vol. 13, №5. - Р. 486-489.
  30. Hwang, K-K. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin / K-K. Hwang, J.M. Grossman, S. Visvanathan et al. // J. Immunol. - 2001. - Vol. 167, №12. - Р. 7192-7198.
  31. Katzav, A. The pathogenesis of neural injury in animal models of the antiphospholipid syndrome / A. Katzav, Y. Shoenfeld, J. Chapman // Clin. Rev. Allergy Immunol. - doi: 10.1007/s12016-009-8154-x. -Published online: 26 June 2009.
  32. Kent, M. Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system / M. Kent, E. Vogt, N.S. Rote // J. Rheumatol. - 1997. -Vol. 24, №9. - Р. 1725-1733.
  33. Kolev, K. Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with antithrombin antibody from a patient with antiphospholipid syndrome / K. Kolev, I. Lerant, J. Skopal et al. // J. Thromb. Haemost. - 2005. - Vol. 94, №1. - Р. 82-87.
  34. Kornberg, A. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies / A. Kornberg, M. Blank, S. Kaufman, Y. Shoenfeld // J. Immunol. - 1994. - Vol.153, №3. - Р. 1328-1332.
  35. McIntyre, J.A. Phospholipid binding plasma proteins required for antiphospholipid antibody detection: an overview / J.A. McIntyre, D.R. Wagenknecht, T. Sugi // Am. J. Reprod. Immunol. - 1997. - Vol. 37, №1. - Р. 101-110.
  36. Minagar, A. Elevated plasma endothelial microparticles in multiple sclerosis / A. Minagar, W. Jy, J.J. Jimenez et al. // Neurology. - 2001. - Vol. 56, №10. - Р. 1319-1324.
  37. Nakajima, H. Clinical manifestations of chronic inflammatory demyelinating polyneuropathy with anti-cardiolipin antibodies / H. Nakajima, K. Shinoda, Y. Doi et al. // Acta neurol. Scan. - 2005. - Vol. 111, №4. - P. 58-63.
  38. Nojima, J. Association between the prevalence of antibodies to в2-glycoprotein 1, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications [with editorial, p985] / J. Nojima, H. Kuratsu, E. Suehisa et al. // Clin. Chem. - 2001. - Vol. 47. - Р. 1008-1015.
  39. Nomura, S. Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura / S. Nomura, M. Yanabu, T. Fukuroi et al. //Ann. Hematol. - 1992. - Vol. 65, №1. - Р. 46-49.
  40. Oosting, J. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanisms? / J. Oosting, R.H. Derkson, I.W.G. Bobbink et al. // Blood. - 1993. - Vol. 81. - Р. 2618-2625.
  41. Rao, L.V.M. Tissue Factor-Factor VIIa Signaling / L.V.M. Rao, U.R. Pendurthi // Arterioscl. Thromb. Vasc. Biol. - 2005. - Vol. 25, №1. - Р. 47-56.
  42. Roubey, R.A. Autoantibodies to phospholipid binding proteins: a new view of lupus anticoagulants and other antiphospholipid autoantibodies // Blood. - 1994. - Vol. 84, №9. - Р. 2854-2867.
  43. Sherer, Y. The idiotypic network in antinuclear-antibody-associated diseases / Y. Sherer, Y. Shoenfeld // Int. Arch. Allergy Immunol. - 2000. - Vol. 123, №1. - Р. 10-15.
  44. Shoenfeld, Y. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer / Y. Shoenfeld, A. Nahum, A.D. Korczyn et al. // Lupus. - 2003. - Vol. 12, №6. - Р. 436-442.
  45. Sokol D.K. Testing for Antiphospholipid Antibody (aPL) Specificities in Retrospective Normal Cerebral Spinal Fluid (CSF) / D.K. Sokol, D.R. Wagenknecht, J.A. McIntyre // Clin. Dev. Immunol. - 2004. - Vol.11, №1. - Р. 7-12.
  46. Vallar, L. Beta 2-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of glycoproteins IIb/IIIa / L. Vallar, V. Regnault, V. Latger-Cannard, T. Lecompte // Thromb. Haemost. - 2001. - Vol. 85, №2. - Р. 314-319.
  47. Yang, C.D. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin / C.D. Yang, K.K. Hwang, W. Yan et al. // Immunol. - 2004. - Vol. 172, №9. - Р. 5765-5773.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Zubairova L.D., Zubairov D.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 75562 от 12 апреля 2019 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies